- Previous Close
62.06 - Open
63.25 - Bid --
- Ask --
- Day's Range
63.07 - 65.60 - 52 Week Range
60.88 - 81.42 - Volume
1,131 - Avg. Volume
9,969 - Market Cap (intraday)
27.539B - Beta (5Y Monthly) 0.53
- PE Ratio (TTM)
0.26 - EPS (TTM)
2.53 - Earnings Date Apr 25, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, federal, and corporate management services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
www.centene.com60,500
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Recent News: 0HVB.L
View MorePerformance Overview: 0HVB.L
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0HVB.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0HVB.L
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
2.25%
Return on Assets (ttm)
3.70%
Return on Equity (ttm)
12.56%
Revenue (ttm)
147.17B
Net Income Avi to Common (ttm)
3.3B
Diluted EPS (ttm)
2.53
Balance Sheet and Cash Flow
Total Cash (mrq)
16.68B
Total Debt/Equity (mrq)
73.29%
Levered Free Cash Flow (ttm)
653.12M